One of hundreds of cannabinoids, cannabichromenic acid (CBCA) may hold an important key to combatting methicillin-resistant Staphylococcus aureus (MRSA), the superbug that kills at least 9,000 people in the US each year and has left healthcare provider…
biopharmaceutical
Clinical trials will test cannabis-based cancer therapy
Two West Coast companies – Pascal Biosciences and SoRSE Technology – are collaborating to move the cannabinoid PAS-393 into clinical trials to test the drug’s effectiveness on a common immune-evading strategy that many metastatic cancers em…